|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
Q4 FY2024
As of Jan 31, 2024
|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $1,101 and $1,064 at July 31, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid VAT and other taxes | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Income tax receivable and other current assets | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating leases right-of-use assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Convertible debt investments | ||||||||||||||||||||
| Convertible debt instruments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accrued earnout agreement | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Loans payable – long term | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term portion of operating lease liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Preferred stock, $0.01 par; authorized 1,500,000 shares (none issued) | ||||||||||||||||||||
| Common stock, $0.01 par; authorized 20,000,000 shares; issued 11,268,067 and 11,164,336; outstanding 9,909,859 and 9,806,128 at July 31, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Treasury stock, at cost; 1,358,208 shares at July 31, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
